Erratum to: Treatment costs of attention deficit hyperactivity disorder in Germany (Eur J Health Econ, (2016), 10.1007/s10198-012-0440-5);Treatment costs of attention deficit hyperactivity disorder in Germany

European Journal of Health Economics

Volumn 14, Issue 6, 2013, Pages 939-945

  Braun, Sebastian ^a   Zeidler, Jan ^b   Linder, Roland ^c   Engel, Susanne ^c   Verheyen, Frank ^c   Greiner, Wolfgang ^d  

^a Herescon GmbH Health Economic Research and Consulting   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c Scientific Institute of TK for Benefit and Efficiency in Health Care   (Germany)

^d BIELEFELD UNIVERSITY   (Germany)

Author keywords

ADHD; Claims data; Costs; Germany; Social health insurance fund

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DEVICE; NEWBORN; OCCUPATIONAL THERAPY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GERMANY; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW;

EID: 84888434695     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-016-0771-8     Document Type: Erratum

References (26)

1. Arbeitsgemeinschaft ADHS der Kinder- und Jugendärzte e.V. (Hrsg.) [ADHD Association of Paediatricians and Adolescent Medical Doctors, registered association (publisher)]. ADHS bei Kindern und Jugendlichen (Aufmerksamkeits- Defizit-Hyperaktivitäts-Störung) - Leitlinie der Arbeitsgemeinschaft ADHS der Kinder- und Jugendärzte e.V [ADHD in Children and Adolescents (Attention Deficit Hyperactivity Disorder) - Guideline of the ADHD Association of Paediatricians and Adolescent Medical Doctors, registered association]. Updated Version January (2007)
2. Alm B. ADHS bei Erwachsenen: Wenn Zappelphilipp erwachsen wird. [ADHD in Adults: If Fidgeting Will Develop.] Dtsch Med Wochenschr (2009); 134, Nr. 24
3. ABDA (Hrsg. [publisher]) - Bundesvereinigung Deutscher Apothekerverbände: Pressemitteilung 30. März (2009). [Federal Union of German Associations of Pharmacists: Press Release 30th March (2009)]. www.abda.de [Download 22/07/2011]
4. Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen [Advisory Council on the Assessment of Developments in the Health Care System]. Gutachten 2009 des Sachverständigenrates zur Begutachtung der Entwicklung im Gesundheitswesen - Koordination und Integration Gesundheitsversorgung in einer Gesellschaft des längeren Lebens [Report 2009 of the Advisory Council on the Assessment of Developments in the Health Care System - Coordination and Integration - Health Care in an Ageing Society]. Köln: Bundesanzeiger Verlag (2009)
5. Schöffski, O.; Sohn, S.; Happich, M.: Die gesamtgesellschaftliche belastung durch die hyperkinetische störung (HKS) bzw. Aufmerksamkeitsdefizit-/hyperaktivitätsstörung (ADHS). Gesundheitswesen 70, 398-403 (2008)
6. Wehmeier, P.M.; Schacht, A.; Rothenberger, A.: Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years. Child. Adolesc. Psychiatr. Mental. Health. 3, 3 (2009). doi: 10.1186/1753-2000-3-3
7. Schöffski, O.: Grundformen gesundheitsökonomischer evaluationen [Basic forms of health economic evaluations]. In: Schöffski, O.; von der Schulenburg, J.M. (eds.) Gesundheitsökonomische Evaluationen, 3rd edn, pp. 65-94. Springer, Berlin (2007)
8. Greiner, W.; Schöffski, O.: Grundprinzipien einer wirtschaftlichkeitsuntersuchung [Basic principles of economic studies]. In: Schöffski, O.; von der Schulenburg, J.M. (eds.) Gesundheitsökonomische Evaluationen, 3rd edn, pp. 167-191. Springer, Berlin (2007)
9. Ärzteblatt (Hrsg. [publisher]). G-BA: ADHS-Medikamente auch für Erwachsene [Joint Federal Committee: ADHD Medication for Adults as Well]. Available at URL: http://www.aerzteblatt.de/nachrichten/46378/G-BA-ADHS- Medikamente-auch-fuer-Erwachsene.htm [Download 19/07/2011]
10. Holle, R.; Behrend, C.; Reitmeir, P.; John, J.: Methodenfragen der Nutzung von GKV-Routinedaten für kostenanalysen [Methodological questions on the use of SHI routine data for cost analyses]. In: Swart, E.; Ihle, P. (eds.) Routinedaten im Gesundheitswesen: Grundlagen, Methoden und Perspektiven, pp. 301-318. Huber, Bern (2005)
11. Prenzler A, Zeidler J, Braun S, von der Schulenburg JM. Bewertung von Ressourcen im Gesundheitswesen aus der Perspektive der deutschen Sozialversicherung [Assessment of health care resources from the viewpoint of the German social insurance]. PharmacoEconomics - German Research Articles 2010; 8(1): 47-66
12. Kassenärztliche Bundesvereinigung (Hrsg.)]National Association of Statutory Health Insurance Physicians (publisher)]. Beschluss des erweiterten Bewertungsausschusses gemäß §87 Abs. 4 SGB V in seiner Sitzung am 23. Oktober 2008 zur Anpassung des Einheitlichen Bewertungsmaßstabs (EBM) sowie zur Neuordnung der vertragsärztlichen Vergütung im Jahr 2009 [Decision of the Extended Valuation Committee Pursuant To Section 87 Paragraph 4 SGB V [Social Security Code V] in its meeting on 23rd October 2008 on the Adjustment of the Uniform Value Scale as well as the Reorganisation of Remunerating SHI Physicians in 2009] Available at URL: http://www.kbv.de/8157. html [Download 19/07/2011]
13. Guevara, J.; Lozano, P.; Wickizer, T.; Mell, L.; Gephart, H.: Utilization and cost of health care services for children with attention-deficit/ hyperactivity disorder. Pediatrics 108, 71-78 (2001)
14. Leibson, C.L.; Katusic, S.K.; Barbaresi, W.J.; Ransom, J.; O'Brien, P.C.: Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 285(1), 60-66 (2001)
15. Chan, E.; Zhan, C.; Homer, C.J.: Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch. Pediatr. Adolesc. Med. 156, 504-511 (2002)
16. Burd, L.; Klug, M.G.; Coumbe, M.J.; Kerbeshian, J.: Children and adolescents with attention deficit-hyperactivity disorder: 1. prevalence and cost of care. J. Child Neurol. 18, 555-561 (2003)
17. Leibson, C.L.; Long, K.H.: Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics 21, 1239-1262 (2003)
18. Swensen, A.R.; Birnbaum, H.G.; Secnik, K.; Marynchenko, M.; Greenberg, P.; Claxton, A.: Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J. Am. Acad. Child Adolesc. Psychiatr. 42(12), 1415-1423 (2003)
19. Birnbaum, H.G.; Kessler, R.C.; Lowe, S.W.; Secnik, K.; Greenberg, P.E.; Leong, S.A.; Swensen, A.R.: Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr. Med. Res. Opin. 21(2), 195-205 (2005)
20. Matza, L.S.; Paramore, C.; Prasad, M.: A review of the economic burden of ADHD. Cost. Eff. Resour. Alloc. 3, 5 (2005). doi: 10.1186/1478-7547-3-5
21. Ray, T.G.; Levine, P.; Croen, L.A.; Bokhari, F.A.S.; Hu, T.W.; Habel, L.A.: Attention-deficit/hyperactivity disorder in children- excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch. Pediatr. Adolesc 160, 1063-1069 (2006)
22. Pelham, W.E.; Foster, M.E.; Robb, J.A.: The economic impact of attention deficit/hyperactivity disorder in children and adolescents. J. Pediatr. Psychol. 32(6), 711-727 (2007)
23. Schlander, M.; Trott, G.E.; Schwarz, O.: Gesundheitsökonomie der aufmerksamkeitsdefizit-/hyperaktivitätsstörung in Deutschland -Teil 1: Versorgungsepidemiologie und krankheitskosten [The health economics of attention deficit hyperactivity disorder in germany. part 1: health care utilization and cost of illness]. Nervenarzt 81(3), 289-300 (2010)
24. Gebhardt B, Finne E, von Rahden O, Kolip P, Glaeske G, Würdemann E. ADHS bei Kindern und Jugendlichen - Befragungsergebnisse und Auswertungen von Daten der Gmünder ErsatzKasse [ADHD in Children and Adolescents - Survey Results and Evaluation of Data of the Gmünder ErsatzKasse]. Schriftenreihe zur Gesundheitsanalyse, Band 65. St. Augustin: Asgard-Verlag (2008)
25. Ruof, J.; Hülsemann, J.L.; Mittendorf, T.; Handelmann, S.; von der Schulenburg, J.M.; Zeidler, H.; Merkesdal, S.: Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann. Rheum. Dis. 62(6), 544-549 (2003)
26. Wu, E.; Chen, L.; Birnbaum, H.; Yang, E.; Cifaldi, M.: Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data. Curr. Med. Res. Opin. 23(8), 1749-1759 (2007)